Delek US (DK) director sells shares at $38.08 under 10b5-1
Delek US Holdings (DK): Form 4 insider transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Delek US Holdings (DK): Form 4 insider transaction. Director Ezra Uzi Yemin reported open‑market sales of common stock on 10/29/2025. He sold 1,581 shares at a weighted average price of $38.08 and, through Yemin Investments, LP, sold 5,807 shares at the same weighted average price.
Following these transactions, beneficial ownership stood at 166,580.047 shares held directly and 723,145 shares held indirectly by Yemin Investments, LP. The trades were made pursuant to a Rule 10b5‑1 plan. The reported price reflects a weighted average of multiple sales ranging from $38.00 to $38.30 per share, with full breakdowns available upon written request.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,581 | $38.08 | $60K |
| Sale | Common Stock | 5,807 | $38.08 | $221K |
Footnotes (2)
- F1. 1. This transaction was pursuant to a Rule 10b5-1 plan.
- F2. The price reflects the weighted average sale price of multiple transactions ranging from $38.00 to $38.30 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Delek US (DK) disclose in this Form 4?
Was this trade under a Rule 10b5-1 plan?
What transaction code was used?
AI-generated analysis. How Rhea-AI works. Not financial advice.